134 related articles for article (PubMed ID: 23592936)
1. Beneficial effect of combination therapy using an angiotensin-converting enzyme inhibitor plus verapamil on circulating resistin levels in hypertensive patients with type 2 diabetes.
Rubio-Guerra AF; Vargas-Robles H; Lozano Nuevo JJ; Elizalde-Barrera CI; Huerta-Ramirez S; Escalante-Acosta BA
Exp Clin Cardiol; 2012; 17(4):202-4. PubMed ID: 23592936
[TBL] [Abstract][Full Text] [Related]
2. The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes.
Rubio-Guerra AF; Vargas-Robles H; Vargas-Ayala G; Rodriguez-Lopez L; Escalante-Acosta BA
Clin Exp Hypertens; 2008 Oct; 30(7):682-8. PubMed ID: 18855271
[TBL] [Abstract][Full Text] [Related]
3. The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes.
Rubio-Guerra AF; Arceo-Navarro A; Vargas-Ayala G; Rodriguez-Lopez L; Lozano-Nuevo JJ; Gomez-Harper CT
Diabetes Care; 2004 Jul; 27(7):1688-91. PubMed ID: 15220247
[TBL] [Abstract][Full Text] [Related]
4. Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension.
Rubio-Guerra AF; Vargas-Robles H; Vargas-Ayala G; Rodríguez-Lopez L; Castro-Serna D; Escalante-Acosta BA
Ther Adv Cardiovasc Dis; 2011 Aug; 5(4):193-7. PubMed ID: 21737486
[TBL] [Abstract][Full Text] [Related]
5. Preclinical considerations and results with the combination of verapamil and trandolapril: blood pressure reduction and beyond.
Kirchengast M
J Hypertens Suppl; 1997 Mar; 15(2):S27-33. PubMed ID: 9218195
[TBL] [Abstract][Full Text] [Related]
6. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.
Muijsers RB; Curran MP; Perry CM
Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112
[TBL] [Abstract][Full Text] [Related]
7. The fixed combination of verapamil SR/trandolapril.
Widimský J
Expert Opin Pharmacother; 2000 Mar; 1(3):515-35. PubMed ID: 11249535
[TBL] [Abstract][Full Text] [Related]
8. [Reduced resistin levels in patients with type 2 diabetes mellitus].
Yang J; Li M; Wu CY; Wang H; Xu QS; Deng JY
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1471-4. PubMed ID: 14521723
[TBL] [Abstract][Full Text] [Related]
9. Association of higher resistin levels with inflammatory activation and endothelial dysfunction in patients with essential hypertension.
Fang C; Lei J; Zhou SX; Zhang YL; Yuan GY; Wang JF
Chin Med J (Engl); 2013 Feb; 126(4):646-9. PubMed ID: 23422182
[TBL] [Abstract][Full Text] [Related]
10. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
11. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
Widimský J; Dzúrik R
Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
[TBL] [Abstract][Full Text] [Related]
12. Preventing microalbuminuria in type 2 diabetes.
Ruggenenti P; Fassi A; Ilieva AP; Bruno S; Iliev IP; Brusegan V; Rubis N; Gherardi G; Arnoldi F; Ganeva M; Ene-Iordache B; Gaspari F; Perna A; Bossi A; Trevisan R; Dodesini AR; Remuzzi G;
N Engl J Med; 2004 Nov; 351(19):1941-51. PubMed ID: 15516697
[TBL] [Abstract][Full Text] [Related]
13. Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats.
Koffi I; Lacolley P; Kirchengaast M; Pomiès JP; Laurent S; Benetos A
Eur J Pharmacol; 1998 Nov; 361(1):51-60. PubMed ID: 9851541
[TBL] [Abstract][Full Text] [Related]
14. Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes.
Schneider M; Lerch M; Papiri M; Buechel P; Boehlen L; Shaw S; Risen W; Weidmann P
J Hypertens; 1996 May; 14(5):669-77. PubMed ID: 8762212
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Noninterventional, Observational Study to Describe the Effectiveness and Safety of Trandolapril and Verapamil Single-Pill Combination in the Management of Patients with Hypertension and Type 2 Diabetes Mellitus: A Harvest TR Study.
Atalar E; Eskin F; Tugtekin HB; Karabulut A; Kanyilmaz S; Kirbiyik H; Ozyildiz AG
Biomed Res Int; 2020; 2020():2123601. PubMed ID: 32964020
[TBL] [Abstract][Full Text] [Related]
16. Insulin sensitivity in hypertensive Type 2 diabetic patients after 1 and 19 days' treatment with trandolapril.
New JP; Bilous RW; Walker M
Diabet Med; 2000 Feb; 17(2):134-40. PubMed ID: 10746484
[TBL] [Abstract][Full Text] [Related]
17. Fixed combination verapamil SR/trandolapril.
Dooley M; Goa KL
Drugs; 1998 Nov; 56(5):837-44; discussion 845-6. PubMed ID: 9829157
[TBL] [Abstract][Full Text] [Related]
18. Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients.
Nakou E; Filippatos TD; Liberopoulos EN; Tselepis AD; Kiortsis DN; Mikhailidis DP; Elisaf MS
Expert Opin Pharmacother; 2008 Jul; 9(10):1629-39. PubMed ID: 18570597
[TBL] [Abstract][Full Text] [Related]
19. Effects of verapamil SR, trandolapril, and their fixed combination on 24-h blood pressure: the Veratran Study.
Veratran Study Group
Am J Hypertens; 1997 May; 10(5 Pt 1):492-9. PubMed ID: 9160758
[TBL] [Abstract][Full Text] [Related]
20. [The effect of trandolapril, in monotherapy and associated with verapamil, on arterial pressure, albuminuria, and metabolic control in hypertensive patients with type 2 diabetes and albuminuria].
Fernández González R; García Robles R; Rodríguez Pérez JC; Gómez Pajuelo C; Moreno Carretero E;
Nefrologia; 2001; 21(5):456-63. PubMed ID: 11795014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
